Table 3.

The relationship between αIE antibodies before CHMI, expression of specific var subclasses after CHMI and PMR (outcome measure). uncorrected p-values are shown

Models	Explanatory variables	Coeff(95% CI)	p-value	Adjusted R2
1	gpA1	1.18(0.06, 2.30)	0.04	13%
2	gpA3	1.55(0.06,3.05)	0.04	12%
3	dc8-1	1.73(0.62,2.85)	0.004	26%
4	gpA_median	0.33(0.03, 0.63)	0.03	14%
5	Dc8_median	1.32(0.07,2.58)	0.04	12%
6	gpA_prop	7.88(2.73,13.02)	0.004	26%
7	dc8_prop	7.85(−0.09,15.79)	0.05	11%
8	c1_prop	−9.26(−14.85, −3.66)	0.003	29%
9	gpA_prop2	7.25(2.77,11.73)	0.003	28%
10	c1_prop2	−8.93(−14.50, −3.37)	0.003	28%
11	αIE	1.99(0.42, 3.55)	0.02	18%
12	gpA1	0.42(−1.12,1.97)	0.6	16%
	αIE	1.55(−0.69,3.80)	0.17
13	gpA3	0.91(−0.69,2.52)	0.3	20%
	αIE	1.54(−0.21,3.28)	0.08
14	dc8-1	1.32(0.06,2.58)	0.04	29%
	αIE	1.12(−0.56,2.80)	0.2
15	gpA_median	0.18 (−0.18, 0.53)	0.3	19%
	αIE	1.44 (−0.46, 3.35)	0.1
16	dc8_median	0.66(−0.81, 2.14)	0.4	18%
	αIE	1.50 (−0.40, 3.41)	0.1
17	gpA_prop	6.0 (−1.08, 13.10)	0.1	25%
	αIE	0.80 (−1.26, 2.85)	0.4
18	dc8_prop	4.65(−3.67, 12.96)	0.3	19%
	αIE	1.59 (−0.12, 3.31)	0.07
19	c1_prop	−7.31 (−13.45, −1.17)	0.02	32%
	αIE	1.13 (−0.47, 2.73)	0.2
20	gpA_prop2	5.80(−0.32,11.92)	0.06	26%
	αIE	0.71(−1.30,2.72)	0.5
21	c1_prop2	−7.0(−13.03, −0.95)	0.03	31%
	αIE	1.18(−0.43,2.78)	0.1